ProHealth health Vitamin and Natural Supplement Store and Health
Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help

|
|
|
|
 
Print Page
Email Article

Nationwide Trial Recruiting 1,350 High Risk Individuals for HIV Vaccine Study

  [ 10 votes ]   [ Post a Comment ]
www.ProHealth.com • September 19, 2010

previous article next article

3-year trial will test non-virus vaccine’s ability to prevent the onset of AIDS in healthy people who subsequently become infected with HIV.

Along with other teams across the US, researchers at University of Texas Southwestern Medical Center are recruiting individuals at high risk of contracting HIV for a nationwide clinical trial to investigate whether the combination of two potential vaccines will stimulate an immune response to the virus that causes AIDS.

The study is funded by the HIV Vaccine Trials Network (HVTN) and the National Institute of Allergy and Infectious Diseases.

“We hope that this trial will help us better understand how the immune system may work to prevent HIV/AIDS,” said infectious diseases researcher Mamta Jain, MD, MPH, principal investigator of the UT Southwestern effort. “It is with this better understanding of the immune system that we may ultimately find a vaccine that may prevent HIV infection.”

Dr. Jain stressed that participants cannot contract HIV from the vaccine.

“This trial may help us better understand why some people develop AIDS and others don’t. If you could prevent people from getting sick from AIDS, that’s a tremendous accomplishment.”

Both components of the combined vaccine, which is designed to produce immune cells called T cells and antibody responses against HIV, have been found safe when tested in animals and hundreds of humans in previous clinical trials.

“The vaccine is composed of man-made proteins that are found in HIV, not the HIV virus itself,” Dr. Jain said. “The vaccine cannot cause infection.”

HIV is transmitted predominantly by unprotected sexual contact with an infected partner. Although huge leaps in scientific knowledge over the past three decades have led to a much better understanding of the complex disease, preventing its spread has proved much more challenging.

Today, someone in the U.S. becomes infected with HIV every 10 minutes.

The study, known as the HVTN 505 study, is designed to determine whether this new combo-vaccine will reduce the HIV viral load of people who subsequently become infected with HIV, preventing the onset of AIDS.

For the clinical trial, 1,350 volunteers nationwide will be assigned randomly to receive either the combination vaccine or a placebo. Forty to 50 people will participate at UT Southwestern; the next closest site is 650 miles from Dallas at the Alabama Vaccine Research Clinic in Birmingham.

“This is the only HIV vaccine trial in the country enrolling participants, so we are very excited to be part of this endeavor,” Dr. Jain said.

Participants in the three-year study:

• Will receive three shots of the research vaccine or a placebo, plus a booster shot, within the first six months.

• And will then return every three months for an HIV test, interview and risk-reduction counseling.

Investigators are seeking to enroll healthy, non-HIV-infected men ages 18 to 45 who have sex with men, and transgender women who have sex with men.

For more information about the clinical trial:

• Call 214-590-0610 or 214-590-0603,

• Or visit www.hopetakesaction.org.

____

Source: University of Texas, Southwestern (Dallas) news release, Sep 10, 2010


previous article
  Rating 3.3 (10 votes) next article




DISCUSS THIS ARTICLE   (0 existing comments) Post a Comment 




[ Be the first to comment on this article ]




 
Free Chronic Fatigue Syndrome and Fibromyalgia Newsletters
Subscribe to
Our FREE
Newsletter
Subscribe Now!
Receive up-to-date ME/CFS & Fibromyalgia treatment and research news
 Privacy Guaranteed  |  View Archives

Save on Your Next Order

Featured Products
Natural Resveratrol Natural Resveratrol
Powerful Antioxidant Support + Positive Anti-aging Effects
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
OsteoTec™ UC-II® OsteoTec™ UC-II®
A True Breakthrough in Joint health
FibroSleep™ by ProHealth FibroSleep™ by ProHealth
The All-in-One Natural Sleep Aid
Omega 3-6-9 Omega 3-6-9
All three EFAs in one convenient form

Most Viewed Articles
What's the Hidden Cause Behind YOUR Fibromyalgia Flares? [more]

Pridgen Reports Fibromyalgia Antiviral Trial Results “Very Positive”: Predicts New Approach Will Be ... [more]

How to Limit or Minimize Your Fibromyalgia Flare [more]

VIDEO: IACFS/ME Conference - Summary of Research by Dr. Komaroff [more]

Mitochondrial Dysfunction, Post-Exertional Malaise and CFS/ME [more]

The Devil Is In The Details – A Herpes Simplex Virus Inquiry For Fibromyalgia and Chronic Fatigue Sy... [more]

Sympathetic Nervous System Dysfunction in FIbromyalgia and Overlapping Conditions [more]

Review of Nutritional Supplements Used for ME/CFS and FM [more]

FREE: Stop Feeding Yourself PAIN Guide [more]

Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel sy... [more]


FIBROMYALGIA RESOURCES
What is Fibromyalgia?
Fibromyalgia 101
Fibromyalgia Symptoms
Fibromyalgia Treatments
| CFS RESOURCES
What is CFS?
ME/CFS 101
ME/CFS Symptoms
ME/CFS Treatments
| FORUMS
Fibromyalgia
ME/CFS
ADVANCED MEDICAL LABS
WHOLESALE  |  AFFILIATES
GUARANTEE
CONTACT US
PRIVACY
RSS
SITE MAP
ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus
Credit Card Processing